Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity. These relationships have been mitigated:
Marla Dubinsky, MD - Disclosures
Grant/Research Support: Janssen
Patent Holder/ Royalties: Takeda
Rishika Chugh, MD - No Disclosures
The PIM planners and others have nothing to disclose. The Crohns & Colitis Foundation planners and others have nothing to disclose.